441 results

Filter

Purulent acute otitis media in adults

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Purulent acute otitis media in children over 3 months

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Acute nasopharyngitis and acute strep throat in children

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Acute nasopharyngitis and acute strep throat in adults

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Adult sinusitis

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Paediatric sinusitis

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Acute simple cystitis, cystitis with risk of complication or recurrent cystitis in women

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Acute pyelonephritis in women

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Pregnant women - urinary colonisation and cystitis

Practice guidelines - Posted on 27/8/2021 - Mis à jour le 27/8/2021

Add to my selection
Focus on patient safety - "Accidents related to a high-risk medicinal product. Who says potassium (KCI) says maximum vigilance"

Tool to improve professional practice - Posted on 5/7/2021

Download document

Add to my selection
See 13 result in Practice Guidelines and Other Guides

OZURDEX (dexamethasone)

Medicine - Posted on 30/9/2021

Add to my selection
DOPTELET (avatrombopag)

Medicine - Posted on 30/9/2021

Add to my selection
EVRYSDI (risdiplam)

Medicine - Posted on 30/9/2021

Add to my selection
TEPADINA (thiotépa)

Medicine - Posted on 28/9/2021

Add to my selection
COAGADEX (facteur X de coagulation humain)

Medicine - Posted on 24/9/2021

Add to my selection
OXLUMO (lumasiran)

Medicine - Posted on 24/9/2021

Add to my selection
MISOONE

Medicine - Posted on 21/9/2021

Add to my selection
BYDUREON (exénatide)

Medicine - Posted on 6/9/2021

Add to my selection
LYXUMIA (lixisénatide)

Medicine - Posted on 6/9/2021

Add to my selection
BYETTA (exénatide)

Medicine - Posted on 6/9/2021

Add to my selection
See 424 result in Drugs, devices and medical acts

Early access to medicinal products

Web page - Posted on 1/7/2021 - Mis à jour le 17/7/2023

Add to my selection
The HAS medication action plan: a first positive assessment is drawn

Press release - Posted on 19/6/2020

Add to my selection
HAS unveils its action plan for innovative medicines

Press release - Posted on 27/1/2020

Add to my selection
Homeopathic medicines : insufficient therapeutic efficacy for reimbursement

Press release - Posted on 28/6/2019 - Mis à jour le 13/2/2020

Add to my selection
See 4 result in Articles and news

My account

You do not have a saved search

No element in selection

441 results

Practice guidelines and other guides - 13 results

Purulent acute otitis media in adults

Purulent acute otitis media in children over 3 months

Acute nasopharyngitis and acute strep throat in children

Acute nasopharyngitis and acute strep throat in adults

Adult sinusitis

Paediatric sinusitis

Acute simple cystitis, cystitis with risk of complication or recurrent cystitis in women

Acute pyelonephritis in women

Pregnant women - urinary colonisation and cystitis

Focus on patient safety - "Accidents related to a high-risk medicinal product. Who says potassium (KCI) says maximum vigilance"

Drugs, devices and medical acts - 424 results

OZURDEX (dexamethasone)

DOPTELET (avatrombopag)

EVRYSDI (risdiplam)

TEPADINA (thiotépa)

COAGADEX (facteur X de coagulation humain)

OXLUMO (lumasiran)

MISOONE

BYDUREON (exénatide)

LYXUMIA (lixisénatide)

BYETTA (exénatide)

Articles and news - 4 results

Early access to medicinal products

The HAS medication action plan: a first positive assessment is drawn

HAS unveils its action plan for innovative medicines

Homeopathic medicines : insufficient therapeutic efficacy for reimbursement

Follow us :